Jonathan Jay Mazelsky - Feb 14, 2023 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
President & CEO, Director
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Jonathan Jay Mazelsky
Stock symbol
IDXX
Transactions as of
Feb 14, 2023
Transactions value $
-$834,548
Form type
4
Date filed
2/16/2023, 05:52 PM
Previous filing
Feb 10, 2023
Next filing
May 5, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +504 +0.71% $0.00 71.3K Feb 14, 2023 Direct
transaction IDXX Common Stock Options Exercise $0 +435 +0.61% $0.00 71.8K Feb 14, 2023 Direct
transaction IDXX Common Stock Options Exercise $0 +974 +1.36% $0.00 72.7K Feb 14, 2023 Direct
transaction IDXX Common Stock Options Exercise $0 +689 +0.95% $0.00 73.4K Feb 14, 2023 Direct
transaction IDXX Common Stock Options Exercise $0 +959 +1.31% $0.00 74.4K Feb 14, 2023 Direct
transaction IDXX Common Stock Tax liability -$835K -1.66K -2.23% $503.65 72.7K Feb 14, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Restricted Stock Unit Options Exercise -504 -3.5% 13.9K Feb 14, 2023 Common Stock 504 Direct F1, F6
transaction IDXX Restricted Stock Unit Options Exercise -435 -3.13% 13.4K Feb 14, 2023 Common Stock 435 Direct F2, F6
transaction IDXX Restricted Stock Unit Options Exercise -974 -7.24% 12.5K Feb 14, 2023 Common Stock 974 Direct F3, F6
transaction IDXX Restricted Stock Unit Options Exercise -689 -5.52% 11.8K Feb 14, 2023 Common Stock 689 Direct F4, F6
transaction IDXX Restricted Stock Unit Options Exercise -959 -8.14% 10.8K Feb 14, 2023 Common Stock 959 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2019.
F2 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.
F3 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.
F4 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.
F5 Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.
F6 Not applicable.